IRWD tops Q2 earnings estimates, misses on revenues and lifts its 2026 outlook as strong Linzess dem

Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2026 Earnings Call Transcript

Ironwood Pharmaceuticals NASDAQ: IRWD reported second-quarter results marked by higher LINZESS sales

Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.31 per share, beating the Zac

[url="]Ironwood Pharmaceuticals, Inc.[/url] (Nasdaq: IRWD), a biotechnology company developing and c

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company deve

Despite the recent market selloff, earnings expectations continue to rise: The S&P 500's Q2 EPS is p

Ironwood Pharmaceuticals trades at a 40% discount to its risk-adjusted sum-of-the-parts valuation, a

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company deve

COLL, IRWD, AMTB and DUK stand out as defensive stock picks as investors rotate from AI-driven tech

Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 34.7% to $0.96 during Tuesday's

Indivior, Aurinia, Ironwood, Altimmune and Marker have been highlighted in this Industry Outlook art

Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, AUPH, IRWD, ALT and MRKR may pr

Ironwood sees Linzess momentum as strong demand, a pediatric expansion and pricing changes are expec

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced that managem

Ironwood gains FDA approval to expand Linzess use to children aged two to five years with functional

[url="]Ironwood Pharmaceuticals, Inc.[/url] (Nasdaq: IRWD), a biotechnology company developing and c

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company deve

Ironwood Pharmaceuticals presents a contrarian buy opportunity after a 14.5% decline driven by CFO r

Ironwood Pharmaceuticals is downgraded to Hold after the CFO's resignation and despite record Q1 202

Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TV

  Friday's session saw 225 companies set new 52-week lows.

  On Wednesday, 179 companies reached new 52-week lows.

  On Tuesday, 210 companies reached new 52-week lows.

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

  During Monday's trading, 528 companies set new 52-week lows.

    This morning 143 companies set new 52-week highs.

    Friday's morning session saw 160 companies set new 52-week highs.

  Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly e

  Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stoc

Stocks That Hit 52-Week Highs On Monday

Stocks That Hit 52-Week Highs On Friday

Stocks That Hit 52-Week Highs On Thursday

Stocks That Hit 52-Week Highs On Wednesday

Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018

Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 7, 2018